2018 Annual Meeting of the European Association for the Study of the Liver*

April 11-15, 2018; Paris, France
Review Capsules Summaries, download slides, and listen to audio commentary from expert-led Webinars covering critical studies on viral hepatitis and NAFLD/NASH from Paris.

NAFLD/NASH

Capsules

Addition of iron-corrected MRI T1 to analysis of PDFF enriched for patients with NASH and significant fibrosis.

Released: April 18, 2018

Patients progressing to end-stage liver disease within 1 year of cirrhosis diagnosis had significantly higher healthcare costs than those without progression.

Released: April 20, 2018

Higher cirrhosis risk in UK and Dutch patients, higher HCC risk in UK patients.

Released: April 19, 2018

Associations between NAFLD prevalence and alcohol use not significant when adjusted for insulin resistance.

Released: April 19, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Educational grant provided by:
AbbVie
Gilead Sciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue